It preferentially binds KDM5A over other KDM5 isoforms, promotes H3K4me3 hypermethylation, and assists in MYC target downregulation and RNAPII phosphorylation; furthermore, it inhibits multiple myeloma cells [74]. Here, KDM5A is linked to plasma cell myeloma.